Sign up / Log in
Sign up / Log in
FEATURED
FEATURED
ADVERTISEMENT

Clinical Pharmacology

Filter by Type:
Juvenile Idiopathic Arthritis (JIA)
Tofacitinib in juvenile idiopathic arthritis: A double-blind, placebo-controlled, withdrawal phase 3 randomised trial
The Lancet | Nov 30
ADVERTISEMENT - SCROLL TO KEEP READING
ADVERTISEMENT - SCROLL TO KEEP READING
ADVERTISEMENT
MORE WORTH YOUR TIME
ADVERTISEMENT

ALSO WORTH YOUR TIME